How Assistance Works
Streamlining our patient’s specialty pharmacy experience with unmatched full-service convenience
-
1. Check Your Coverage/Benefits Verification
Our team of expert billers finds the best avenues of coverage that minimize out-of-pocket costs.
-
2. Transfer Prescription to AmeriPharma®
We process your prescription by working with your previous pharmacy or prescriber, making the transition quick and easy.
-
3. Prior Authorization
Our team of specialists obtains approval from your insurance companies within 24 to 72 hours.
-
4. Copay Assistance & Financial Aid
We secure financial aid and decrease copays, out-of-pocket expenses, and high deductibles. To date, AmeriPharma® Specialty Care has secured $55 million in financial assistance for our patients.
-
5. Nursing Care Coordination If Needed
AmeriPharma® puts your schedule and home environment first when scheduling and coordinating one of our specialized nurses for your in-home infusions.
-
6. Delivery Coordination
Medications are always delivered in strict compliance with the specific requirements for shipping. Next-day and overnight cold-chain deliveries are coordinated around your schedule.
What Is FEIBA?
FEIBA (or factor 8 inhibitor bypass activity) is used in patients who have hemophilia A or B and have developed inhibitors (antibodies) against the clotting factor medications (i.e., factor VIII or IX).
Hemophilia, a genetic disorder, is treated with clotting factor medications that help control bleeding episodes in patients. However, in some cases, the patient’s bodies start to produce antibodies (inhibitors) against these drugs, neutralize their effects, and make them less effective in preventing bleeding episodes.
FEIBA, a medication also known by its generic name “anti-inhibitor coagulant complex,” works by bypassing the activity of these inhibitors and promoting blood clotting in patients with clotting factor inhibitors.
If your doctor has prescribed you FEIBA, this page will help you learn important details about this drug.
What is FEIBA Used for?
The FDA has approved FEIBA infusions to be used in the following conditions in patients with hemophilia A or B with inhibitors:
- To control and prevent acute bleeding episodes
- To control excessive bleeding before, during, or after a surgical procedure
- For routine prophylaxis to prevent or reduce the frequency of bleeding episodes
However, it is not indicated to treat bleeding episodes in patients who do not have inhibitors against factors VIII or IX.
Composition and Mode of Action
FEIBA is a plasma-derived product and consists of multiple activated and non-activated clotting factors, including factors II, VII, IX, and X. It promotes blood clotting even in the presence of inhibitors (antibodies) in hemophilia A or hemophilia B patients.
Patients with hemophilia A can develop antibodies against clotting factor VIII, while hemophilia B patients can develop antibodies against clotting factor IX. These antibodies (inhibitors) neutralize the effects of factor VIII or IX drugs, making them less effective in controlling or preventing bleeds.
FEIBA bypasses the activity of these inhibitors and makes sure that the blood clots properly. It is important to know that this hemophilia medication does not cure your condition but only helps to control bleeding episodes.
Copay and Financial Assistance
AmeriPharma® Specialty Pharmacy alleviates financial burdens for patients and their families
-
Advanced software locates funding sources to match you with top-dollar foundation programs
-
One of our copay assistance specialists will assist with the application process
-
Automatic updates will be sent to you and your physician on the status of the funding
FEIBA Dosing and Administration
FEIBA is a medication that comes in the form of lyophilized powder in single-dose vials containing concentrations of 500, 1,000, or 2,500 units per vial.
FEIBA is administered intravenously, and the drug’s dosage is tailored based on the patient’s clinical condition and the severity of the bleeding episodes.
1. Control and Prevention of Bleeding Episodes
Patients with minor to moderate bleeds may receive a dose of 50 – 100 units/kg FEIBA infusions, which is repeated every 6 – 12 hours until bleeding is resolved.
In cases of major bleeds (i.e., severe hemorrhage), the dose of FEIBA is increased to 100 units/kg with intervals adjusted based on clinical response.
2. Surgical Prophylaxis
Patients undergoing surgical procedures receive 50 – 100 units/kg of the FEIBA medication immediately before surgery. Furthermore, additional doses may be given after the surgery, every 6 – 12 hours, until the bleeding is resolved and the damaged area is healed.
3. Routine Prophylaxis
In routine prophylaxis, a dose of 85 units/kg is administered every other day. The dose and frequency are adjusted according to the extent of bleeding and the patient’s clinical conditions.
FEIBA Side Effects
Common side effects include:
- Anemia
- Diarrhea
- Hemarthrosis
- Hepatitis B surface antibody-positive
- Nausea
- Vomiting
Insurances Accepted
We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.
Get Started in Minutes
Fill out your information and one of our specialists will call you ASAP.
How Much Can You Save?
Complete this form to save up to 100%!
By submitting, you agree to AmeriPharma’s Terms of Use, Privacy Policy, and Notice of Privacy Practices